• Inozyme Pharma, Inc. (NASDAQ:INZY) Receives Average Rating of "Buy" from Analysts

    Source: Buzz FX / 04 Feb 2025 02:51:08   America/New_York


    Inozyme Pharma, Inc. (NASDAQ:INZY) Receives Average Rating of "Buy" from Analysts Written by MarketBeat February 4, 2025 Share Link copied to clipboard. Inozyme Pharma, Inc. ( NASDAQ:INZY - Get Free Report ) has earned an average rating of
    Read more...
Share on,